A simple way to enhance Doxil® therapy: Drug release from liposomes at the tumor site by amphiphilic block copolymer

Journal of Controlled Release

Volumn 168, Issue 1, 2013, Pages 61-69

  Zhao, Yi ^a   Alakhova, Daria Y ^a,c   Kim, Jong Oh ^a,d   Bronich, Tatiana K ^a   Kabanov, Alexander V ^a,b,c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c University of North Carolina   (United States)

^d Yeungnam University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIPHILIC BLOCK COPOLYMERS; ANTI-TUMOR EFFICACY; ANTITUMOR EFFECT; CYTOTOXIC EFFECTS; CYTOTOXICITY ASSAYS; OVARIAN CANCERS; PLURONIC BLOCK COPOLYMERS; THERAPEUTIC EFFICACY;

BLOCK COPOLYMERS; CYTOTOXICITY; DRUG PRODUCTS; LIPOSOMES;

TUMORS;

BROMINE DERIVATIVE; DOXORUBICIN; LIPOSOME; PLURONIC P85; POLOXAMER; THIAZOLYL BLUE TETRAZOLIUM BROMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CANCER CELL; CANCER LOCALIZATION; CONFOCAL MICROSCOPY; DRUG ACCUMULATION; DRUG RELEASE; FEMALE; FLUORESCENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; DOXORUBICIN; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASMS; POLOXALENE; POLYETHYLENE GLYCOLS;

EID: 84875670920     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.02.026     Document Type: Article

References (53)

1. G. Song, H. Wu, K. Yoshino, and W.C. Zamboni Factors affecting the pharmacokinetics and pharmacodynamics of liposomal drugs J. Liposome Res. 22 2012 177 192
2. R.A. Schwendener Liposomes in biology and medicine Adv. Exp. Med. Biol. 620 2007 117 128
3. N. Maurer, D.B. Fenske, and P.R. Cullis Developments in liposomal drug delivery systems Expert. Opin. Biol. Ther. 1 2001 923 947
4. V.P. Torchilin Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 4 2005 145 160
5. H. Maeda, T. Sawa, and T. Konno Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS J. Control. Release 74 2001 47 61
6. K. Kostarelos, D. Emfietzoglou, A. Papakostas, W.H. Yang, A. Ballangrud, and G. Sgouros Binding and interstitial penetration of liposomes within avascular tumor spheroids Int. J. Cancer 112 2004 713 721
7. V.P. Chauhan, T. Stylianopoulos, Y. Boucher, and R.K. Jain Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies Annu. Rev. Chem. Biomol. Eng. 2 2011 281 298
8. F. Yuan, M. Leunig, S.K. Huang, D.A. Berk, D. Papahadjopoulos, and R.K. Jain Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft Cancer Res. 54 1994 3352 3356
9. R. Kalluri, and M. Zeisberg Fibroblasts in cancer Nat. Rev. Cancer 6 2006 392 401
10. N.A. Bhowmick, E.G. Neilson, and H.L. Moses Stromal fibroblasts in cancer initiation and progression Nature 432 2004 332 337
11. B. Diop-Frimpong, V.P. Chauhan, S. Krane, Y. Boucher, and R.K. Jain Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors Proc. Natl. Acad. Sci. U. S. A. 108 2011 2909 2914
12. L. Eikenes, I. Tufto, E.A. Schnell, A. Bjorkoy, and C. De Lange Davies Effect of collagenase and hyaluronidase on free and anomalous diffusion in multicellular spheroids and xenografts Anticancer. Res. 30 2010 359 368
13. K.N. Sugahara, T. Teesalu, P.P. Karmali, V.R. Kotamraju, L. Agemy, D.R. Greenwald, and E. Ruoslahti Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs Science 328 2010 1031 1035
14. R.K. Jain, and T. Stylianopoulos Delivering nanomedicine to solid tumors Nat. Rev. Clin. Oncol. 7 2010 653 664
15. A. Schroeder, R. Honen, K. Turjeman, A. Gabizon, J. Kost, and Y. Barenholz Ultrasound triggered release of cisplatin from liposomes in murine tumors J. Control. Release 137 2009 63 68
16. G. Kong, G. Anyarambhatla, W.P. Petros, R.D. Braun, O.M. Colvin, D. Needham, and M.W. Dewhirst Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release Cancer Res. 60 2000 6950 6957
17. E. Hagtvet, K. Roe, and D.R. Olsen Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts Radiat. Oncol. 6 2011 135
18. K.J. Harrington, G. Rowlinson-Busza, K.N. Syrigos, R.G. Vile, P.S. Uster, A.M. Peters, and J.S. Stewart Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model Clin. Cancer Res. 6 2000 4939 4949
19. A. Khaibullina, B.S. Jang, H. Sun, N. Le, S. Yu, V. Frenkel, J.A. Carrasquillo, I. Pastan, K.C. Li, and C.H. Paik Pulsed high-intensity focused ultrasound enhances uptake of radiolabeled monoclonal antibody to human epidermoid tumor in nude mice J. Nucl. Med. 49 2008 295 302
20. Y.C. Barenholz Doxil(R) - the first FDA-approved nano-drug: lessons learned J. Control. Release 2012 117 134
21. W.C. Zamboni Concept and clinical evaluation of carrier-mediated anticancer agents Oncologist 13 2008 248 260
22. W.C. Zamboni Liposomal, nanoparticle, and conjugated formulations of anticancer agents Clin. Cancer Res. 11 2005 8230 8234
23. I.K. Kwon, S.C. Lee, B. Han, and K. Park Analysis on the current status of targeted drug delivery to tumors J. Control. Release 164 2012 108 114
24. Y.H. Bae, and K. Park Targeted drug delivery to tumors: myths, reality and possibility J. Control. Release 153 2011 198 205
25. A.T. Florence Reductionism and complexity in nanoparticle-vectored drug targeting J. Control. Release 161 2012 399 402
26. X. Yi, M.C. Zimmerman, R. Yang, J. Tong, S. Vinogradov, and A.V. Kabanov Pluronic-modified superoxide dismutase 1 attenuates angiotensin II-induced increase in intracellular superoxide in neurons Free Radic. Biol. Med. 49 2010 548 558
27. G. Sahay, E.V. Batrakova, and A.V. Kabanov Different internalization pathways of polymeric micelles and unimers and their effects on vesicular transport Bioconjug. Chem. 19 2008 2023 2029
28. R.I. Pakunlu, Y. Wang, M. Saad, J.J. Khandare, V. Starovoytov, and T. Minko In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug J. Control. Release 114 2006 153 162
29. Y. Wang, M. Saad, R.I. Pakunlu, J.J. Khandare, O.B. Garbuzenko, A.A. Vetcher, V.A. Soldatenkov, V.P. Pozharov, and T. Minko Nonviral nanoscale-based delivery of antisense oligonucleotides targeted to hypoxia-inducible factor 1 alpha enhances the efficacy of chemotherapy in drug-resistant tumor Clin. Cancer Res. 14 2008 3607 3616
30. N. Rapoport, A. Marin, Y. Luo, G.D. Prestwich, and M.D. Muniruzzaman Intracellular uptake and trafficking of Pluronic micelles in drug-sensitive and MDR cells: effect on the intracellular drug localization J. Pharm. Sci. 91 2002 157 170
31. E.V. Batrakova, S. Li, Y. Li, V.Y. Alakhov, and A.V. Kabanov Effect of pluronic P85 on ATPase activity of drug efflux transporters Pharm. Res. 21 2004 2226 2233
32. E.H. Herman, A. Rahman, V.J. Ferrans, J.A. Vick, and P.S. Schein Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation Cancer Res. 43 1983 5427 5432
33. K.M. Laginha, S. Verwoert, G.J. Charrois, and T.M. Allen Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors Clin. Cancer Res. 11 2005 6944 6949
34. M.L. Immordino, F. Dosio, and L. Cattel Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential Int. J. Nanomedicine 1 2006 297 315
35. L. Harris, G. Batist, R. Belt, D. Rovira, R. Navari, N. Azarnia, L. Welles, and E. Winer Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma Cancer 94 2002 25 36
36. T.O. Price, S.A. Farr, X. Yi, S. Vinogradov, E. Batrakova, W.A. Banks, and A.V. Kabanov Transport across the blood-brain barrier of pluronic leptin J. Pharmacol. Exp. Ther. 333 2010 253 263
37. A.V. Kabanov, E.V. Batrakova, and V.Y. Alakhov Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery J. Control. Release 82 2002 189 212
38. E.V. Batrakova, and A.V. Kabanov Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers J. Control. Release 130 2008 98 106
39. J.W. Valle, A. Armstrong, C. Newman, V. Alakhov, G. Pietrzynski, J. Brewer, S. Campbell, P. Corrie, E.K. Rowinsky, and M. Ranson A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction Investig. New Drugs 29 2011 1029 1037
40. S. Danson, D. Ferry, V. Alakhov, J. Margison, D. Kerr, D. Jowle, M. Brampton, G. Halbert, and M. Ranson Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer Br. J. Cancer 90 2004 2085 2091
41. D.Y. Alakhova, N.Y. Rapoport, E.V. Batrakova, A.A. Timoshin, S. Li, D. Nicholls, V.Y. Alakhov, and A.V. Kabanov Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers J. Control. Release 142 2010 89 100
42. E.V. Batrakova, S. Li, A.M. Brynskikh, A.K. Sharma, Y. Li, M. Boska, N. Gong, R.L. Mosley, V.Y. Alakhov, H.E. Gendelman, and A.V. Kabanov Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers J. Control. Release 143 2010 290 301
43. E.V. Batrakova, S. Li, Y. Li, V.Y. Alakhov, W.F. Elmquist, and A.V. Kabanov Distribution kinetics of a micelle-forming block copolymer Pluronic P85 J. Control. Release 100 2004 389 397
44. E.V. Batrakova, S. Li, V.Y. Alakhov, W.F. Elmquist, D.W. Miller, and A.V. Kabanov Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85 Pharm. Res. 20 2003 1581 1590
45. E.V. Batrakova, Y. Zhang, Y. Li, S. Li, S.V. Vinogradov, Y. Persidsky, V.Y. Alakhov, D.W. Miller, and A.V. Kabanov Effects of pluronic P85 on GLUT1 and MCT1 transporters in the blood-brain barrier Pharm. Res. 21 2004 1993 2000
46. V.Y. Erukova, O.O. Krylova, Y.N. Antonenko, and N.S. Melik-Nubarov Effect of ethylene oxide and propylene oxide block copolymers on the permeability of bilayer lipid membranes to small solutes including doxorubicin Biochim. Biophys. Acta 1468 2000 73 86
47. J.Y. Wang, J. Marks, and K.Y. Lee Nature of interactions between PEO-PPO-PEO triblock copolymers and lipid membranes: (I) effect of polymer hydrophobicity on its ability to protect liposomes from peroxidation Biomacromolecules 13 2012 2616 2623
48. C.Y. Cheng, J.Y. Wang, R. Kausik, K.Y. Lee, and S. Han Nature of interactions between PEO-PPO-PEO triblock copolymers and lipid membranes: (II) role of hydration dynamics revealed by dynamic nuclear polarization Biomacromolecules 13 2012 2624 2633
49. G. Sahay, J.O. Kim, A.V. Kabanov, and T.K. Bronich The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents Biomaterials 31 2010 923 933
50. E. Batrakova, S. Lee, S. Li, A. Venne, V. Alakhov, and A. Kabanov Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells Pharm. Res. 16 1999 1373 1379
51. A.V. Kabanov, E.V. Batrakova, and V.Y. Alakhov Pluronic block copolymers for overcoming drug resistance in cancer Adv. Drug Deliv. Rev. 54 2002 759 779
52. A. Gabizon, D. Tzemach, L. Mak, M. Bronstein, and A.T. Horowitz Dose dependency of pharmacokinetics and therapeutic efficacy of pegylated liposomal doxorubicin (DOXIL) in murine models J. Drug Target. 10 2002 539 548
53. H. Maeda The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting Adv. Enzyme Regul. 41 2001 189 207